INSOMNIA IN PANIC DISORDER. LITERATURE REWIEW
https://doi.org/10.33667/2782-4101-2023-2-4-9
Abstract
Sleep disorders and panic disorder (PD) are often comorbid and closely interrelated. Sleep disorders aggravate the severity of panic disorder, and pathological anxiety worsens sleep. In this regard, the treatment of insomnia in patients with PD is aimed at harmonizing the emotional state and correcting sleep and, along with pharmacotherapy, includes a wide range of psychotherapeutic methods. Successful treatment of insomnia increases the effectiveness of PD therapy, reduces the likelihood of relapse and increases the susceptibility of patients to many anti-anxiety drugs.
Supporting agencies: e. The work was supported by the RSF grant No 22- 28-00540 (https://rscf.ru/project/22-28-00540/). The article was prepared with the support of Krewel Meuselbach Ltd.
About the Authors
E. A. Korabelnikova
I.M. Sechenov First Moscow State Medical University (Sechenov University; Russian State Humanitarian University
Russian Federation
Russian Federation
Korabelnikova Elena Alexandrovna, neurologist, MD, professor, Department of nervous diseases, I.M. Sechenov First Moscow State Medical University (Sechenov University); Russian State Humanitarian University
Moscow, Tel. +7-910-414-09-34.
E. V. Yakovleva
Private healthcare institution «Central clinical hospital «RZD-Medicine»; Russian State Humanitarian University
Russian Federation
Russian Federation
Yakovleva Elena Vyacheslavovna, neurologist, private healthcare institution «Central clinical hospital «RZD-Medicine»; Russian State Humanitarian University
Moscow, Tel. +7-919-047-95-32.
References
1. Korabelnikova EA. Sleep disturbances in panic disorders. S.S. Korsakov Journal of Neurology and Psychiatry. Special issues. 2018; 118(4–2): 99–106. (In Russ.) DOI: 10.17116/jnevro20181184299
2. WHO. ICD‑10. International statistical classification of diseases and related health problems (10th revision). Classification of mental and behavioral disorders.
3. DSM–IV. Diagnostic and Statistical Mannual of mental disorders. Washington; 1990.
4. Dyukova G.M. Panic disorders in the practice of a neurologist. Remedium Privolzh’e. 2017; 2(152): 21–24. (In Russ.)
5. Shin J., Park D., Ryu S. et al. Clinical implications of agoraphobia in patients with panic disorder. Medicine (Baltimore). 2020; 99(30): e21414. DOI: 10.1097/MD.0000000000021414
6. Cousineau H., Marchand A., Bouchard S. et al. Insomnia symptoms following treatment for comorbid panic disorder with agoraphobia and generalized anxiety disorder. J. Nerv. Mental Dis. 2016; 4: 267–273. DOI: 10.1097NMD.0000000000000466
7. Brook A., Marcks B., Weisberg R. Co-occurrence of insomnia and anxiety disorders: a review of the literature. Am. J. Lifestyle Med. 2009; 3(4): 300–309. DOI: 10.1177/1559827609334681
8. Hauri P., Friedman M., Ravaris C. Sleep in patients with spontaneous panic attacks. Sleep. 1989; 12(4): 323–337. DOI: 10.1093/sleep/12.4.323
9. Kovrov G.V., Lebedev M.A., Palatov S. Yu. et al. Sleep disorders in anxiety and anx- iety-depressive disorders. Russian Medical Journal. 2015; 10: 530–536. (In Russ.)
10. Mishiev V.D. Sleep disorders in certain mental disorders: a modern approach to choosing a hypnotist. News of Medicine and Pharmacy. 2007; (3): 9–11. (In Russ.)
11. Na H.R., Kang E.H., Yu B.H. et al. Relationship between personality and insomnia in panic disorder patients. Psychiatry Invest. 2011; 8(2): 102–106. DOI: 10.4306/pi.2011.8.2.102
12. Uhde T., Cortese B., Vedeniapin A. Anxiety and sleep problems: emerging concepts and theoretical treatment implications. Curr. Psychiatry Rep. 2009; 11(4): 269–276. DOI: 10.1007/s11920-009-0039-4
13. Van de Laar M., Verbeek I., Pevernagie D. The role of personality traits in insomnia. Sleep Med. Rev. 2010; 14(1): 61–68. PMID: 19897388. DOI: 10.1016/j.smrv.2009.07.007
14. Belleville G., Marchand A., Poitra J. et al. Do treatments for panic disorder improve sleep in patients with unexplained chest pain. Arch. Sci. Psychol. 2015; 3: 93–100. DOI: 10.1037/arc0000018
15. Zugliani M., Martin-Santos R., Nardi A., Freire R. Personality traits in panic disorder patients with and without comorbidities. J. Nerv. Ment. Dis. 2017; 205(11): 855–858. DOI: 10.1097/NMD.0000000000000745
16. Perlis R., Mischoulon D., Smoller J. et al. Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment. Biol. Psychiatry. 2003; 54(9): 879–883. DOI: 10.1016/s0006–3223 (03) 00424-4
17. Brummett B., Krystal A., Ashley-Koch A. et al. Sleep quality varies as a func- tion of 5-HTTLPR genotype and stress. Psychosom. Med. 2007; 69(7): 621–624. DOI: 10.1097/PSY.0b013e31814b8de6
18. Yumatov E. A., Glazachev O. S., Bykova E. V. et al. Relationship between emo- tional stress and sleep. Vestnik MAN RS. 2016; (1): 5–14. (In Russ.)
19. Vorobyeva O. V. The role of emotional stress in the development of panic disorder. Mental disorders in general medicine. 2008; (4): 48–51. (In Russ.)
20. Poluektov M. G., Buzunov R. V., Averbuh V. M. et al. Draft clinical guidelines for the diagnosis and treatment of chronic insomnia in adults. Neurology and Rheu- matology. 2016; (2): 41–51. (In Russ.)
21. Vorobyeva O.V. Panic disorder –principles of therapy. Russian Medical Journal. 2008; 6: 362–365. (In Russ.)
22. Zinkovsky A.K., Yurov I.E. Personality features and psychovegetative status of patients with panic and generalized anxiety disorder. Social and Clinical Psychia- try. 2001; (2): 44–48. (In Russ.)
23. Poluektov M.G. Sleep disorders in the practice of a psychiatrist. Modern therapy of mental disorders. 2012; (4): 11–17. (In Russ.)
24. National Institutes of Health. National Institutes of Health State of the Sci- ence Conference statement on Manifestations and Management of Chronic In- somnia in Adults. Sleep. 2005; 28(9): 1049–1057. DOI: 10.1093/sleep/28.9.1049
25. Sateia M., Doghramji K., Hauri P., Morin C. Evaluation of chronic insomnia. Sleep. 2000; 23(2): 243–308.
26. Morin C. Cognitive-behavioral approaches to the treatment of insomnia. Clin. Psychiatry. 2004; 65(Suppl 16): 33–40.
27. Golubev V. L., Bashmakov M. Yu. Panic attacks and a night’s sleep. Russian Med- ical Journal. 1999; 2(1): 3–6. (In Russ.)
28. Pecknold J., Olha A., Chang H. et al. Sleep architecture in patients with panic disorders. Proceedings of 1 meeting of the Collegium Intenationale Neuro-Psy- chopharmacologicumin. San Juan; 1986.
29. Hauri P., Friedman M., Ravaris C. Sleep in patients with spontaneous panic attacks. Sleep. 1989; 12(4): 323–337. DOI: 10.1093/sleep/12.4.323
30. Hoge E., Marques L., Wechsler R. et al. The role of anxiety sensitivity in sleep disturbance in panic disorder. J. Anxiety Disord. 2011; 25(4): 536–538. DOI: 10.1016/j.janxdis.2010.12.008
31. Uhde T., Roy-Byrne P., Gillin J. et al. The sleep of patients with panic disor- der: a preliminary report. Psychiatry Res. 1985; 12(3): 251–259. DOI: 10.1016/0165–1781 (84) 90030-1
32. Lesser I., Poland R., Holcomb C., Rose D. Electroencephalographic study of nighttime panic attacks. J. Nerv. Ment. Dis. 1985; 173(12): 744–746. DOI: 10.1097/00005053-198512000-00007
33. Mellman T., Uhde T. Sleep-related panic. Proceedings of 42nd Annual Conven- tion of the Society for Biological Psychiatry. Chicago; 1987.
34. Bell C., Dixie-Bell D., Thompson B. Panic attacks: relationship to isolated sleep paralysis. Am. J. Psychiatry. 1986; 143(11): 1484. DOI: 10.1176/ajp.143.11.1484a
35. Wade A. Antidepressants in panic disorder. Intern. Clin. Psychopharmacol. 1999; 14(2): 13–17.
36. DeVane C. The place of selective serotonin reuptake inhibitors in the treat- ment of panic disorder. Pharmacotherapy. 1997; 17(2): 282–292.
37. Roy-Byrne P., Craske M., Stein M. Panic disorder. Lancet. 2006; 368(9540): 1023–1032. DOI: 10.1016/S0140–6736(06)69418-X
38. Sepede G., De Berardis D., Gambi F. et al. Olanzapine augmentation in treatment-resistant panic disorder: a 12-week, fixed dose, open-label trial. J. Clin. Psychopharmacol. 2006; 26(1): 45–49. DOI: 10.1097/01.jcp.0000195108.01898.17
39. Simon N., Hoge E., Fischmann D. et al. An open-label trial of risperidone augmentation for refractory anxiety disorders. J. Clin. Psychiatry. 2006; 67(3): 381–385. DOI: 10.4088/jcp.v67n0307
40. Wayne A.M. Panic attacks. Guide for doctors. Мoscow; 2004. (In Russ.)
41. Korabelnikova E.A. A modern approach to the diagnosis and therapy of panic disorder. Polyclinic. 2016; (3–4): 31–36. (In Russ.)
42. Breilmann J., Girlanda F., Guaiana G. et al. Benzodiazepines versus placebo for panic disorder in adults. Cochrane Database Syst. Rev. 2019; 3(3): CD010677. DOI: 10.1002/14651858.CD010677.pub2
43. Riemann D., Baglioni C., Bassetti C. et al. European guideline for the diag- nosis and treatment of insomnia. J. Sleep Res. 2017; 26(6): 675–700. DOI: 10.1111/jsr.12594
44. Zakharov A.V., Khivintseva E.V. Clinical use of melatonin in the treatment of sleep disorders. Effective pharmacotherapy. 2019; 15(44): 42–47. DOI 10.33978/2307-3586-2019-15-44-42-47
45. Korabelnikova E.A. Psychotherapy of insomnia: the role of the somnologist and psychotherapist. Effective pharmacotherapy. Neurology and psychiatry. Special issue “Sleep and its disorders”. 2014; (12): 38–44. (In Russ.)
46. Qaseem A., Kansagara D., Forciea M. et al. Management of chronic insom- nia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann. Intern. Med. 2016; 165(2): 125–133. DOI: 10.7326/M15–2175
47. Medic G., Wille M., Hemels M. Short- and long-term health consequences of sleep disruption. Nat. Sci. Sleep. 2017; 9: 151–161. DOI: 10.2147/NSS.S134864
48. Mendelson W. A review of the evidence for the efficacy and safety of trazo- done in insomnia. J. Clin. Psychiatry. 2005; 66(4): 469–476. DOI: 10.4088/jcp.v66n0409
49. Everitt H., Baldwin D., Stuart B. et al. Antidepressants for insomnia in adults. Cochrane Database Syst. Rev. 2018; 5(5): CD 010753. DOI: 10.1002/14651858.CD010753.pub2
50. Burchakov D.I., Tardov M.V. Insomnia in the practice of a therapist: the role of doxylamine. Medical advice. 2020; (2): 45–53. (In Russ.) DOI: 10.21518/2079–701X-2020-2-45-53.
51. Allison M., Hale C. A phase I study of the pharmacokinetics and pharma- codynamics of intranasal doxylamine in subjects with chronic intermittent sleep impairment. Drugs R D. 2018; 18(2): 129–136. DOI: 10.1007/s40268-018-0232-1
52. Smulevich A.B., Zheleznova M.V., Pavlova L.K. The use of “Donormil” in the treatment of sleep disorders of moderate and mild severity in the practice of a psychiatrist. Psychiatry and psychopharmacotherapy. 2006. 8(1): 21–28. (In Russ.)
53. Asnis G. M., Caneva E., Henderson M. А. Treatment of insomnia in anxiety disorders. Psychiatric Times. 2012; 29(1).
Review
For citations:
Korabelnikova E.A., Yakovleva E.V. INSOMNIA IN PANIC DISORDER. LITERATURE REWIEW. International journal of Innovative Medicine. 2023;(2):4-9. https://doi.org/10.33667/2782-4101-2023-2-4-9
Views:
448
Email this article 